Enhancing slow wave sleep with sodium oxybate to reduce the behavioral and physiological impact of sleep loss

Trial Profile

Enhancing slow wave sleep with sodium oxybate to reduce the behavioral and physiological impact of sleep loss

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2008

At a glance

  • Drugs Sodium oxybate (Primary)
  • Indications Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2008 Actual end date changed from 1 May 2008 to 1 May 2008 as reported by ClinicalTrials.gov.
    • 29 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top